{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:24:52Z","timestamp":1791289492771,"version":"4.3.0"},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.2169\/internalmedicine.5407-25","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T22:07:30Z","timestamp":1752703650000},"page":"457-463","source":"Crossref","is-referenced-by-count":1,"title":["Urinary \u03b22-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial Nephritis"],"prefix":"10.2169","volume":"65","author":[{"given":"Nozomi","family":"Taniguchi","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Sakai","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Masuda","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Asakura-Kinoshita","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Misawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuho","family":"Oe","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Oka","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Hishida","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Dokkyo Medical University, Japan"},{"name":"Department of Nephrology and Hypertension, Saitama Medical Center, Saitama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Akimoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nagata","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 366: 539-551, 2012.","DOI":"10.1056\/NEJMra1104650"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kawano M, Saeki T, Ubara Y, Matsui S. Recent advances in IgG4-related kidney disease. Mod Rheumatol 33: 242-251, 2023.","DOI":"10.1093\/mr\/roac065"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Buglioni A, Jenkins SM, Nasr SH, et al. Clinicopathologic features of IgG4-related kidney disease. Kidney Int Rep 9: 2462-2473, 2024.","DOI":"10.1016\/j.ekir.2024.05.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Peyronel F, Vaglio A. IgG4-related kidney disease. Clin J Am Soc Nephrol 18: 994-996, 2023.","DOI":"10.2215\/CJN.0000000000000235"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wakabayashi K, Yanagawa H, Hayashi Y, et al. Progressive renal dysfunction due to IgG4-related kidney disease refractory to steroid therapy: a case report. Case Rep Nephrol Dial 9: 1-7, 2019.","DOI":"10.1159\/000496465"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31: 529-533, 2021.","DOI":"10.1080\/14397595.2020.1859710"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Saeki T, Kawano M, Nagasawa T, et al. Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version. Clin Exp Nephrol 25: 99-109, 2021.","DOI":"10.1007\/s10157-020-01993-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zaarour M, Weerasinghe C, Eter A, El-Sayegh S, El-Charabaty E. An overlapping case of lupus nephritis and IgG4-related kidney disease. J Clin Med Res 7: 575-581, 2015.","DOI":"10.14740\/jocmr2189w"},{"key":"9","unstructured":"9. Johnson SR, Brinks R, Costenbader KH, et al. Performance of the 2019 EULAR\/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis 79: 1333-1339, 2020."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22: 1343-1352, 2011.","DOI":"10.1681\/ASN.2011010062"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22: 21-30, 2012.","DOI":"10.3109\/s10165-011-0571-z"},{"key":"12","unstructured":"12. Karim AF, Bansie RD, Rombach SM, et al. The treatment outcomes in IgG4-related disease. Neth J Med 76: 275-285, 2018."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mizushima I, Yamada K, Fujii H, et al. A case of IgG4-related kidney disease first detected because of severe renal dysfunction. In: IgG4-Related Disease. Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, Eds. Springer Japan, Tokyo, 2014: 213-218.","DOI":"10.1007\/978-4-431-54228-5_30"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Saeki T, Kawano M, Mizushima I, et al. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol 20: 87-93, 2016.","DOI":"10.1007\/s10157-015-1140-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mizushima I, Yamamoto M, Inoue D, et al. Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study. Arthritis Res Ther 18: 273, 2016.","DOI":"10.1186\/s13075-016-1175-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Saeki T, Kawano M, Mizushima I, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int 84: 826-833, 2013.","DOI":"10.1038\/ki.2013.191"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz&apos;s disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 37: 1380-1385, 2010.","DOI":"10.3899\/jrheum.091153"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Aoki A, Sato K, Itabashi M, et al. A case of Mikulicz&apos;s disease complicated with severe interstitial nephritis associated with IgG4. Clin Exp Nephrol 13: 367-372, 2009.","DOI":"10.1007\/s10157-008-0127-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Masuda T, Akimoto T, Ando Y, et al. Changes in the urinary excretion of \u03b22-microglobulin (\u03b22MG) and N-acetyl-\u03b2-D-glucosaminidase (NAG) during treatment for lupus nephritis. Intern Med 47: 287-290, 2008.","DOI":"10.2169\/internalmedicine.47.0464"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hishida E, Ono Y, Oe K, et al. Acute interstitial nephritis with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination. Intern Med 62: 2381-2387, 2023.","DOI":"10.2169\/internalmedicine.1631-23"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Matsumoto M, Yamamoto S, Yokoi H, et al. A case of IgG4-related disease manifesting as extensive abdominal periarteritis and membranous nephropathy, successfully controlled with low-dose steroid therapy without relapse or complications. Nephron 149: 213-221, 2025.","DOI":"10.1159\/000542414"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Barton KT, Kakajiwala A, Dietzen DJ, Goss CW, Gu H, Dharnidharka VR. Using the newer Kidney Disease: Improving Global Outcomes criteria, beta-2-microglobulin levels associate with severity of acute kidney injury. Clin Kidney J 11: 797-802, 2018.","DOI":"10.1093\/ckj\/sfy056"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ono K, Masuda T, Ono Y, et al. Severe acute interstitial nephritis induced by \u03b1-glucosidase inhibitor miglitol in an elderly patient with type 2 diabetic nephropathy. Intern Med 63: 2827-2831, 2024.","DOI":"10.2169\/internalmedicine.3156-23"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zeng X, Hossain D, Bostwick DG, Herrera GA, Zhang PL. Urinary \u03b22-microglobulin is a good indicator of proximal tubule injury: a correlative study with renal biopsies. J Biomark 2014: 492838, 2014.","DOI":"10.1155\/2014\/492838"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ix JH, Shlipak MG. The promise of tubule biomarkers in kidney disease: a review. Am J Kidney Dis 78: 719-727, 2021.","DOI":"10.1053\/j.ajkd.2021.03.026"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Jotwani V, Garimella PS, Katz R, et al. Tubular biomarkers and chronic kidney disease progression in SPRINT participants. Am J Nephrol 51: 797-805, 2020.","DOI":"10.1159\/000509978"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Malhotra R, Katz R, Jotwani V, et al. Urine markers of kidney tubule cell injury and kidney function decline in SPRINT trial participants with CKD. Clin J Am Soc Nephrol 15: 349-358, 2020.","DOI":"10.2215\/CJN.02780319"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hsu CY, Xie D, Waikar SS, et al. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int 91: 196-203, 2017.","DOI":"10.1016\/j.kint.2016.09.003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Vikse BE, Aasar\u00f8d K, Bostad L, Iversen BM. Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant 18: 517-523, 2003.","DOI":"10.1093\/ndt\/18.3.517"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Singh AK, Ucci A, Madias NE. Predominant tubulointerstitial lupus nephritis. Am J Kidney Dis 27: 273-278, 1996.","DOI":"10.1016\/S0272-6386(96)90553-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mori Y, Kishimoto N, Yamahara H, et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis. Clin Exp Nephrol 9: 79-84, 2005.","DOI":"10.1007\/s10157-004-0338-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5407-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:46:43Z","timestamp":1770436003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5407-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5407-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"5407-25"}}